Light from sunshine bill may reach more targets
Executive SummaryCo-sponsors of the Physicians Payment Sunshine Act are discussing broadening its beam to cover more recipients of industry funding. Medicare Payment Advisory Commission has recommended that a public database include not only pharmaceutical and device company payments to physicians, but also to academic medical centers, continuing medical education organizations and patient and physician advocacy groups (1"The Pink Sheet," Sept. 8, 2008, p. 20). It is anticipated that CME providers will be covered when PPSA is reintroduced in 2009, according to a staffer at the Senate Aging Committee, whose chairman, Herb Kohl, D-Wis., co-authored the bill with Sen. Chuck Grassley, R-Iowa
You may also be interested in...
Keeping Track: US FDA's Rejection Of First RMAT BLA Blemishes Otherwise Positive Week Of Non-Oncology News
The latest non-oncology drug development news and highlights from our US FDA Performance Tracker.
Stephen Hahn, the Trump administration’s nominee to lead the US FDA, has been approved by the Senate Health, Education, Labor and Pensions (HELP) Committee, with some “no votes” from Democratic senators in leadership positions, and is expected to be considered by the full Senate this week.